Complete Genomics Inc (GNOM) Return on Equity ROE from the third quarter 2012 to third quarter 2011 and annually, average high and low, overall ranking from Sep 30 2012 to Sep 30 2011 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Complete Genomics Inc  (GNOM)
    Sector • Healthcare    Industry • Medical Laboratories
   Industry • Medical Laboratories
   Sector • Healthcare

Complete Genomics Inc's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for Complete Genomics Inc in the third quarter 2012?
Complete Genomics Inc recorded a cumulative net loss of $-57 million during 12 months ending in the third quarter 2012, resulting in a negative return on equity (ROE) of -100.14%.

Within the Medical Laboratories industry Complete Genomics Inc achieved the highest return on equity. While the total ranking for ROE unchanged, relative to the second quarter 2012 at no. .

What is ROE?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Equity (Sep 30 2012)
III. Quarter		 (Jun 30 2012)
II. Quarter		 (Mar 31 2012)
I. Quarter		 (Dec 31 2011)
IV. Quarter		 (Sep 30 2011)
III. Quarter
Y / Y Equity Change -68.39 % -60.61 % -12.49 % - -
Y / Y Net Income Change - - - - -
Net Income (TTM) in Millions -57 -61 -58 -50 -70
Return On Equity (TTM) -100.14 % -81.41 % -62.06 % -52.42 % -94.26 %
GNOM's Total Ranking # # # # #
Equity (TTM) in Millions 32 48 64 83 103
Seq. Equity Change -32.94 % -24.93 % -22 % -19.5 % -16.45 %
Seq. Net Income Change - - - - -

Back to GNOM Management Effectiveness >> GNOM's 5 Years Annual ROE >> Compare GNOM ROE to its Competitors
Return On Equity Company Ranking
Within: No.
Industry #
Sector #
Overall #

Return On Equity Statistics
High Average Low
0 %
0 %
0 %
 





GNOM Annual Return On Equity (Dec 31 2011)
2011



Total Equity in Millions 83 0 0 0 0
Y / Y Equity Change - - - - -
Net Income in Millions -72 0 0 0 0
Y / Y Net Income Change - - - - -
Return On Equity -87.57 % - - - -

Back to GNOM Management Effectiveness >> GNOM's 5 Years Annual ROE >> Compare GNOM ROE to its Competitors




More Return On Equity Ratios
Medical Laboratories Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
GNOM's' Return on Equity at Yahoo Finance
GNOM's Roe Ratio versus Medical Laboratories Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for GNOM's Competitors
Subscribers only: Roe for Complete Genomics Inc's Suppliers
Subscribers only: Return On Equity for GNOM's Customers




Companies with similar Return On Equity at Sep 30 2012, within Healthcare Sector ROE

Date modified: 2026-09-08T15:07:16+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.